Zheng, Q., Huang, Y., Zhao, H., Yang, Y., Hong, S., Hou, X., . . . Zhang, L. (2020). EGFR mutation genotypes affect efficacy and resistance mechanisms of osimertinib in T790M-positive NSCLC patients. Transl Lung Cancer Res.
Chicago Style aipamenaZheng, Qiufan, et al. "EGFR Mutation Genotypes Affect Efficacy and Resistance Mechanisms of Osimertinib in T790M-positive NSCLC Patients." Transl Lung Cancer Res 2020.
MLA aipamenaZheng, Qiufan, et al. "EGFR Mutation Genotypes Affect Efficacy and Resistance Mechanisms of Osimertinib in T790M-positive NSCLC Patients." Transl Lung Cancer Res 2020.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.